Sample Entry:
BioCommerce Data's Biotechnology Company Compendium 2001/2: Europe
|
november AG
Ulrich-Schalk-Strasse 3
november is a life science company involved in research, development and commercialisation of new technologies in the field of molecular medicine Products under development in the company's three business areas include: in molecular therapy, polyoma virus capsids as artificial transport vehicles for drug delivery and T-cell specific immunotherapy; in molecular diagnosis, a specific molecular analysis device for medical diagnosis, a test kit including capillary polymerase chain reaction (PCR), electrohybridisation (detection, purification and enrichment of specific nucleic acids), molecular labelling of solid and liquid bulk products, and labelling of stock animals using an immunologic eartag; in medical products, a coagulation kit (novi quick®) and a finger lancing device for obtaining capillary blood. Major investors include venture capital firms and the management. The company is looking to become a listed company on the Neuer Markt, Germany. |
Year founded 1996 Total staff at main site 61 on 31/10/2000 Financial data for year ending 31/12/1999 Stock exchanges [ticker symbols, if any] Products and Services Interest Areas Key executives
|
© PJB Publications Ltd. 2001 All rights reserved. |